Lower-middle income (World Bank) vs Marshall Islands: HIV-positive TB patients on ART (antiretroviral therapy)
Lower-middle income (World Bank)
95.0%
in 2024
Marshall Islands
100.0%
in 2019
Lower-middle income (World Bank) rank
3rd
Marshall Islands rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Lower-middle income (World Bank)
- Marshall Islands
How they compare
Marshall Islands currently reports 100.0% against 95.0% in Lower-middle income (World Bank), a difference of 5.0%.
That makes Marshall Islands's figure about 1.1 times Lower-middle income (World Bank)'s.
Across all 5 years both countries report, Marshall Islands has been ahead every year.
Lower-middle income (World Bank) ranks 3rd and Marshall Islands ranks 1st of 11 groups.
Marshall Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lower-middle income (World Bank) | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.0% | 100.0% | 64.0% | Marshall Islands |
| 2010s | 76.5% | 100.0% | 23.5% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Lower-middle income (World Bank) or Marshall Islands?
- Marshall Islands, at 100.0% against 95.0% in Lower-middle income (World Bank) as of 2019.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Lower-middle income (World Bank) and Marshall Islands?
- 5.0%, with Marshall Islands ahead.
- How many years of comparable data are there for Lower-middle income (World Bank) and Marshall Islands?
- 5 years are reported by both, from 2009 to 2019.
- How do Lower-middle income (World Bank) and Marshall Islands rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Lower-middle income (World Bank) ranks 3rd and Marshall Islands ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.